• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SCUBE3 是一种内源性 TGF-β 受体配体,可调节肺癌中的上皮-间充质转化。

SCUBE3 is an endogenous TGF-β receptor ligand and regulates the epithelial-mesenchymal transition in lung cancer.

机构信息

Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan, ROC.

出版信息

Oncogene. 2011 Aug 25;30(34):3682-93. doi: 10.1038/onc.2011.85. Epub 2011 Mar 28.

DOI:10.1038/onc.2011.85
PMID:21441952
Abstract

Signal peptide-CUB-EGF-like domain-containing protein 3 (SCUBE3) is a secreted glycoprotein that is overexpressed in lung cancer tumor tissues and is correlated with the invasive ability in a lung cancer cell line model. These observations suggest that SCUBE3 may have a role in lung cancer progression. By exogenous SCUBE3 treatment or knockdown of SCUBE3 expression, we found that SCUBE3 could promote lung cancer cell mobility and invasiveness. Knockdown of SCUBE3 expression also suppressed tumorigenesis and cancer metastasis in vivo. The secreted SCUBE3 proteins were cleaved by gelatinases (matrix metalloprotease-2 (MMP-2) and MMP-9) in media to release two major fragments: the N-terminal epidermal growth factor-like repeats and the C-terminal complement proteins C1r/C1s, Uegf and Bmp1 (CUB) domain. Both the purified SCUBE3 protein and the C-terminal CUB domain fragment, bound to transforming growth factor-β (TGF-β) type II receptor through the C-terminal CUB domain, activated TGF-β signaling and triggered the epithelial-mesenchymal transition (EMT). This process includes the induction of Smad2/3 phosphorylation, the increase of Smad2/3 transcriptional activity and the upregulation of the expression of target genes involved in EMT and cancer progression (such as TGF-β1, MMP-2, MMP-9, plasminogen activator inhibitor type-1, vascular endothelial growth factor, Snail and Slug), thus promoting cancer cell mobility and invasion. In conclusion, in lung cancer cells, SCUBE3 could serve as an endogenous autocrine and paracrine ligand of TGF-β type II receptor, which could regulate TGF-β receptor signaling and modulate EMT and cancer progression.

摘要

信号肽-CUB-EGF 样结构域蛋白 3(SCUBE3)是一种分泌性糖蛋白,在肺癌肿瘤组织中过度表达,与肺癌细胞系模型中的侵袭能力相关。这些观察结果表明,SCUBE3 可能在肺癌进展中发挥作用。通过外源性 SCUBE3 处理或 SCUBE3 表达的敲低,我们发现 SCUBE3 可以促进肺癌细胞的迁移和侵袭性。SCUBE3 表达的敲低也抑制了体内的肿瘤发生和癌症转移。分泌的 SCUBE3 蛋白被明胶酶(基质金属蛋白酶-2(MMP-2)和 MMP-9)在介质中切割,释放两个主要片段:N 端表皮生长因子样重复序列和 C 端补体蛋白 C1r/C1s、Uegf 和 Bmp1(CUB)结构域。纯化的 SCUBE3 蛋白和 C 端 CUB 结构域片段都通过 C 端 CUB 结构域与转化生长因子-β(TGF-β)Ⅱ型受体结合,激活 TGF-β 信号并引发上皮-间充质转化(EMT)。这个过程包括诱导 Smad2/3 磷酸化、增加 Smad2/3 转录活性以及上调 EMT 和癌症进展相关的靶基因(如 TGF-β1、MMP-2、MMP-9、纤溶酶原激活物抑制剂 1、血管内皮生长因子、Snail 和 Slug)的表达,从而促进癌细胞的迁移和侵袭。总之,在肺癌细胞中,SCUBE3 可以作为 TGF-β Ⅱ型受体的内源性自分泌和旁分泌配体,调节 TGF-β 受体信号并调节 EMT 和癌症进展。

相似文献

1
SCUBE3 is an endogenous TGF-β receptor ligand and regulates the epithelial-mesenchymal transition in lung cancer.SCUBE3 是一种内源性 TGF-β 受体配体,可调节肺癌中的上皮-间充质转化。
Oncogene. 2011 Aug 25;30(34):3682-93. doi: 10.1038/onc.2011.85. Epub 2011 Mar 28.
2
Transgenic overexpression of the secreted, extracellular EGF-CUB domain-containing protein SCUBE3 induces cardiac hypertrophy in mice.分泌型含细胞外EGF-CUB结构域蛋白SCUBE3的转基因过表达可诱导小鼠心脏肥大。
Cardiovasc Res. 2007 Jul 1;75(1):139-47. doi: 10.1016/j.cardiores.2007.03.014. Epub 2007 Mar 20.
3
Thyroid transcription factor-1 inhibits transforming growth factor-beta-mediated epithelial-to-mesenchymal transition in lung adenocarcinoma cells.甲状腺转录因子-1抑制肺腺癌细胞中转化生长因子-β介导的上皮-间质转化。
Cancer Res. 2009 Apr 1;69(7):2783-91. doi: 10.1158/0008-5472.CAN-08-3490. Epub 2009 Mar 17.
4
EGCG inhibits transforming growth factor-β-mediated epithelial-to-mesenchymal transition via the inhibition of Smad2 and Erk1/2 signaling pathways in nonsmall cell lung cancer cells.EGCG 通过抑制 Smad2 和 Erk1/2 信号通路抑制非小细胞肺癌细胞中的转化生长因子-β介导的上皮-间充质转化。
J Agric Food Chem. 2012 Oct 3;60(39):9863-73. doi: 10.1021/jf303690x. Epub 2012 Sep 19.
5
Regulation of extracellular matrix remodeling following transforming growth factor-beta1/epidermal growth factor-stimulated epithelial-mesenchymal transition in human premalignant keratinocytes.转化生长因子-β1/表皮生长因子刺激人癌前角质形成细胞发生上皮-间质转化后细胞外基质重塑的调控
Cells Tissues Organs. 2007;185(1-3):116-22. doi: 10.1159/000101312.
6
Activation of TGF-β1 Pathway by SCUBE3 Regulates TWIST1 Expression and Promotes Breast Cancer Progression.SCUBE3 通过激活 TGF-β1 通路调节 TWIST1 的表达并促进乳腺癌进展。
Cancer Biother Radiopharm. 2020 Mar;35(2):120-128. doi: 10.1089/cbr.2019.2990. Epub 2019 Nov 19.
7
An novel inhibitor of TGF-β type I receptor, IN-1130, blocks breast cancer lung metastasis through inhibition of epithelial-mesenchymal transition.一种新型 TGF-β 型 I 受体抑制剂 IN-1130 通过抑制上皮-间充质转化阻断乳腺癌肺转移。
Cancer Lett. 2014 Aug 28;351(1):72-80. doi: 10.1016/j.canlet.2014.05.006. Epub 2014 Jun 2.
8
Epithin, a target of transforming growth factor-beta signaling, mediates epithelial-mesenchymal transition.表皮黏附素是转化生长因子-β信号的靶标,介导上皮-间充质转化。
Biochem Biophys Res Commun. 2010 May 14;395(4):553-9. doi: 10.1016/j.bbrc.2010.04.065. Epub 2010 Apr 14.
9
Loss of type III transforming growth factor beta receptor expression increases motility and invasiveness associated with epithelial to mesenchymal transition during pancreatic cancer progression.III型转化生长因子β受体表达缺失会增加胰腺癌进展过程中与上皮-间质转化相关的迁移和侵袭能力。
Carcinogenesis. 2008 Feb;29(2):252-62. doi: 10.1093/carcin/bgm249. Epub 2007 Nov 13.
10
Epilysin (MMP-28) induces TGF-beta mediated epithelial to mesenchymal transition in lung carcinoma cells.表皮溶素(基质金属蛋白酶-28)诱导肺癌细胞中转化生长因子-β介导的上皮-间质转化。
J Cell Sci. 2006 Sep 15;119(Pt 18):3856-65. doi: 10.1242/jcs.03157. Epub 2006 Aug 29.

引用本文的文献

1
Single Cell RNA Sequencing of Papillary Cancer Mesenchymal Stem/Stromal Cells Reveals a Transcriptional Profile That Supports a Role for These Cells in Cancer Progression.乳头状癌间充质干/基质细胞的单细胞RNA测序揭示了一种转录谱,该转录谱支持这些细胞在癌症进展中的作用。
Int J Mol Sci. 2025 May 21;26(10):4957. doi: 10.3390/ijms26104957.
2
A Novel Homozygous Missense Variant with Protein Modeling in a Patient Diagnosed as Short Stature, Facial Dysmorphism, and Skeletal Anomalies with or without Cardiac Anomalies 2.一名被诊断为身材矮小、面部畸形以及伴有或不伴有心脏异常的骨骼异常患者中发现的一种具有蛋白质建模的新型纯合错义变异2 。
Mol Syndromol. 2025 Mar 28:1-9. doi: 10.1159/000545570.
3
Molecular pathological insights into tumorigenesis and progression of giant cell tumor of bone.
骨巨细胞瘤发生发展的分子病理学见解
J Bone Oncol. 2025 Feb 19;51:100665. doi: 10.1016/j.jbo.2025.100665. eCollection 2025 Apr.
4
Non-small cell lung cancer map and analysis: exploring interconnected oncogenic signal integrators.非小细胞肺癌图谱与分析:探索相互关联的致癌信号整合因子
Mamm Genome. 2025 Feb 12. doi: 10.1007/s00335-025-10110-6.
5
Striking a balance: new perspectives on homeostatic dendritic cell maturation.寻求平衡:稳态树突状细胞成熟的新视角
Nat Rev Immunol. 2025 Feb;25(2):125-140. doi: 10.1038/s41577-024-01079-5. Epub 2024 Sep 17.
6
The biology of SCUBE.SCUBE 的生物学特性。
J Biomed Sci. 2023 May 26;30(1):33. doi: 10.1186/s12929-023-00925-3.
7
Epithelium-derived SCUBE3 promotes polarized odontoblastic differentiation of dental mesenchymal stem cells and pulp regeneration.上皮细胞衍生的 SCUBE3 促进牙间充质干细胞的极化成牙本质分化和牙髓再生。
Stem Cell Res Ther. 2023 May 15;14(1):130. doi: 10.1186/s13287-023-03353-0.
8
Delineating the dynamic evolution from preneoplasia to invasive lung adenocarcinoma by integrating single-cell RNA sequencing and spatial transcriptomics.通过整合单细胞 RNA 测序和空间转录组学,描绘从癌前病变到浸润性肺腺癌的动态演变过程。
Exp Mol Med. 2022 Nov;54(11):2060-2076. doi: 10.1038/s12276-022-00896-9. Epub 2022 Nov 25.
9
The Multifaceted Role of Signal Peptide-CUB-EGF Domain-Containing Protein (SCUBE) in Cancer.信号肽-CUB-EGF 域蛋白(SCUBE)在癌症中的多效作用。
Int J Mol Sci. 2022 Sep 12;23(18):10577. doi: 10.3390/ijms231810577.
10
Aberrant paracrine signalling for bone remodelling underlies the mutant histone-driven giant cell tumour of bone.异常的旁分泌信号导致破骨细胞重塑,这是突变组蛋白驱动的骨巨细胞瘤的基础。
Cell Death Differ. 2022 Dec;29(12):2459-2471. doi: 10.1038/s41418-022-01031-x. Epub 2022 Aug 3.